-
1
-
-
0036323216
-
Incidence of uveal melanoma in Sweden from 1960 to 1998
-
Bergman L, Seregard S, Nilsson B, et al. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 2002;43:2579-83. (Pubitemid 34809445)
-
(2002)
Investigative Ophthalmology and Visual Science
, vol.43
, Issue.8
, pp. 2579-2583
-
-
Bergman, L.1
Seregard, S.2
Nilsson, B.3
Ringborg, U.4
Lundell, G.5
Ragnarsson-Olding, B.6
-
2
-
-
57449091278
-
Ocular melanoma: Relatively rare but requiring respect
-
Shields CL, Shields JA. Ocular melanoma: relatively rare but requiring respect. Clin Dermatol 2009;27:122-33.
-
(2009)
Clin Dermatol
, vol.27
, pp. 122-133
-
-
Shields, C.L.1
Shields, J.A.2
-
3
-
-
0036845612
-
Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites
-
Tuomaala S, Eskelin S, Tarkkanen A, et al. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanomas in whites. Invest Ophthalmol Vis Sci 2002;43:3399-408. (Pubitemid 35334346)
-
(2002)
Investigative Ophthalmology and Visual Science
, vol.43
, Issue.11
, pp. 3399-3408
-
-
Tuomaala, S.1
Eskelin, S.2
Tarkkanen, A.3
Kivela, T.4
-
4
-
-
61449129472
-
Mortality after uveal and conjunctival melanoma: Which tumour is more deadly?
-
Kujala E, Tuomaala S, Eskelin S, et al. Mortality after uveal and conjunctival melanoma: which tumour is more deadly? Acta Ophthalmol 2009;87:149-53.
-
(2009)
Acta Ophthalmol
, vol.87
, pp. 149-153
-
-
Kujala, E.1
Tuomaala, S.2
Eskelin, S.3
-
6
-
-
67349216128
-
Effectiveness of treatments for metastatic uveal melanoma
-
Augsburger JJ, Correa ZM, Shaikh AH. Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 2009;148:119-27.
-
(2009)
Am J Ophthalmol
, vol.148
, pp. 119-127
-
-
Augsburger, J.J.1
Correa, Z.M.2
Shaikh, A.H.3
-
7
-
-
63049123398
-
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma
-
discussion 135-7
-
Augsburger JJ, Correa ZM, Shaikh AH. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Trans Am Ophthalmol Soc 2008;106:128-35; discussion 135-7.
-
(2008)
Trans Am Ophthalmol Soc
, vol.106
, pp. 128-135
-
-
Augsburger, J.J.1
Correa, Z.M.2
Shaikh, A.H.3
-
9
-
-
34249323028
-
+ T lymphocytes that cross-react with primary and metastatic uveal melanoma cells
-
DOI 10.1158/0008-5472.CAN-06-3770
-
Bosch JJ, Thompson JA, Srivastava MK, et al. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells. Cancer Res 2007;67:4499-506. (Pubitemid 46815101)
-
(2007)
Cancer Research
, vol.67
, Issue.9
, pp. 4499-4506
-
-
Bosch, J.J.1
Thompson, J.A.2
Srivastava, M.K.3
Iheagwara, U.K.4
Murray, T.G.5
Lotem, M.6
Ksander, B.R.7
Ostrand-Rosenberg, S.8
-
10
-
-
70350121598
-
Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8(+) cytotoxic, tumor-specific T cells
-
Bosch JJ, Iheagwara UK, Reid S, et al. Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8(+) cytotoxic, tumor-specific T cells. Cancer Immunol Immunother 2010;59:103-12.
-
(2010)
Cancer Immunol Immunother
, vol.59
, pp. 103-112
-
-
Bosch, J.J.1
Iheagwara, U.K.2
Reid, S.3
-
11
-
-
23144464171
-
Cancer/testis antigens, gametogenesis and cancer
-
DOI 10.1038/nrc1669
-
Simpson AJ, Caballero OL, Jungbluth A, et al. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005;5:615-25. (Pubitemid 41081387)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.8
, pp. 615-625
-
-
Simpson, A.J.G.1
Caballero, O.L.2
Jungbluth, A.3
Chen, Y.-T.4
Old, L.J.5
-
12
-
-
32944457941
-
Tumor antigen expression in melanoma varies according to antigen and stage
-
DOI 10.1158/1078-0432.CCR-05-1544
-
Barrow C, Browning J, MacGregor D, et al. Tumor antigen expression in melanoma varies according to antigen and stage. Clin Cancer Res 2006;12:764-71. (Pubitemid 43259856)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.3 I
, pp. 764-771
-
-
Barrow, C.1
Browning, J.2
MacGregor, D.3
Davis, I.D.4
Sturrock, S.5
Jungbluth, A.A.6
Cebon, J.7
-
13
-
-
34447508326
-
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors
-
Velazquez EF, Jungbluth AA, Yancovitz M, et al. Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors. Cancer Immun 2007;7:11-17.
-
(2007)
Cancer Immun
, vol.7
, pp. 11-17
-
-
Velazquez, E.F.1
Jungbluth, A.A.2
Yancovitz, M.3
-
14
-
-
63549100184
-
Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma
-
Nicholaou T, Ebert LM, Davis ID, et al. Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma. Clin Cancer Res 2009;15:2166-73.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2166-2173
-
-
Nicholaou, T.1
Ebert, L.M.2
Davis, I.D.3
-
15
-
-
79954586180
-
Genetics of uveal melanoma and cutaneous melanoma: Two of a kind?
-
van den Bosch T, Kilic E, Paridaens D, et al. Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract 2010;2010:360136.
-
(2010)
Dermatol Res Pract
, vol.2010
, pp. 360136
-
-
Van Den Bosch, T.1
Kilic, E.2
Paridaens, D.3
-
16
-
-
3242881864
-
BRAF mutations in conjunctival melanoma
-
DOI 10.1167/iovs.04-0093
-
Gear H, Williams H, Kemp EG, et al. BRAF mutations in conjunctival melanoma. Invest Ophthalmol Vis Sci 2004;45:2484-8. (Pubitemid 38998840)
-
(2004)
Investigative Ophthalmology and Visual Science
, vol.45
, Issue.8
, pp. 2484-2488
-
-
Gear, H.1
Williams, H.2
Kemp, E.G.3
Roberts, F.4
-
17
-
-
15844380371
-
Infrequent expression of the MAGE gene family in uveal melanomas
-
DOI 10.1002/(SICI)1097-0215(19960611)66:6<738::AID-IJC5>3.0.CO;2-0
-
Mulcahy KA, Rimoldi D, Brasseue F, et al. Infrequent expression of the MAGE gene family in uveal melanomas. Int J Cancer 1996;66:738-42. (Pubitemid 26197940)
-
(1996)
International Journal of Cancer
, vol.66
, Issue.6
, pp. 738-742
-
-
Mulcahy, K.A.1
Rimoldi, D.2
Brasseur, F.3
Rodgers, S.4
Lienard, D.5
Marchand, M.6
Rennie, I.G.7
Murray, A.K.8
McIntyre, C.A.9
Platts, K.E.10
Leyvraz, S.11
Boon, T.12
Rees, R.C.13
-
18
-
-
0030816455
-
Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease
-
Chen PW, Murray TG, Uno T, et al. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease. Clin Exp Metastasis 1996;15:509-18.
-
(1996)
Clin Exp Metastasis
, vol.15
, pp. 509-518
-
-
Chen, P.W.1
Murray, T.G.2
Uno, T.3
-
19
-
-
0031916525
-
Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines
-
DOI 10.1097/00008390-199802000-00003
-
Luyten GP, van der Spek CW, Brand I, et al. Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines. Melanoma Res 1998;8:11-16. (Pubitemid 28114296)
-
(1998)
Melanoma Research
, vol.8
, Issue.1
, pp. 11-16
-
-
Luyten, G.P.M.1
Van Der, S.C.W.2
Brand, I.3
Sintnicolaas, K.4
De Waard-Siebinga, I.5
Jager, M.J.6
De Jong, P.T.V.M.7
Schrier, P.I.8
Luider, T.M.9
-
20
-
-
0031436618
-
Expression of MAGE genes in ocular melanoma cell lines
-
DOI 10.1097/00002371-199707000-00003
-
Chen PW, Murray TG, Salgaller ML, et al. Expression of MAGE genes in ocular melanoma cell lines. J Immunother 1997;20:265-75. (Pubitemid 28011538)
-
(1997)
Journal of Immunotherapy
, vol.20
, Issue.4
, pp. 265-275
-
-
Chen, P.W.1
Murray, T.G.2
Salgaller, M.L.3
Ksander, B.R.4
-
21
-
-
79251593379
-
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate
-
Svobodová S, Browning J, MacGregor D, et al. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. Eur J Cancer 2011;47:460-9.
-
(2011)
Eur J Cancer
, vol.47
, pp. 460-469
-
-
Svobodová, S.1
Browning, J.2
MacGregor, D.3
-
22
-
-
33746224212
-
Desmoplastic melanoma: Comparison of expression of differentiation antigens and cancer testis antigens
-
DOI 10.1097/01.cmr.0000222588.22493.3f, PII 0000839020060800000010
-
Lim E, Browning J, MacGregor D, et al. Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens. Melanoma Res 2006;16:347-55. (Pubitemid 44090179)
-
(2006)
Melanoma Research
, vol.16
, Issue.4
, pp. 347-355
-
-
Lim, E.1
Browning, J.2
MacGregor, D.3
Davis, I.D.4
Cebon, J.S.5
-
23
-
-
0031757416
-
High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma
-
de Vries TJ, Trancikova D, Ruiter DJ, et al. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma. Br J Cancer 1998;78:1156-61. (Pubitemid 28479143)
-
(1998)
British Journal of Cancer
, vol.78
, Issue.9
, pp. 1156-1161
-
-
De Vries, T.J.1
Trancikova, D.2
Ruiter, D.J.3
Van Muijen, G.N.P.4
-
24
-
-
0035159576
-
Expression of gp100, MART-I, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: Implications for diagnosis and immunotherapy. A study conducted by the EORTC melanoma cooperative group
-
DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH729>3.0.CO;2-D
-
de Vries TJ, Smeets M, de Graaf R, et al. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group. J Pathol 2001;193:13-20. (Pubitemid 32051107)
-
(2001)
Journal of Pathology
, vol.193
, Issue.1
, pp. 13-20
-
-
De Vries, T.J.1
Smeets, M.2
De Graaf, R.3
Hou-Jensen, K.4
Brocker, E.B.5
Renard, N.6
Eggermont, A.M.M.7
Van Muijen, G.N.P.8
Ruiter, D.J.9
-
25
-
-
0038697491
-
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen
-
DOI 10.1089/104303403765255110
-
Rosenberg SA, Yang JC, Sherry RM, et al. Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen. Hum Gene Ther 2003;14:709-14. (Pubitemid 36623509)
-
(2003)
Human Gene Therapy
, vol.14
, Issue.8
, pp. 709-714
-
-
Rosenberg, S.A.1
Yang, J.C.2
Sherry, R.M.3
Hwu, P.4
Topalian, S.L.5
Schwartzentruber, D.J.6
Restifo, N.P.7
Haworth, L.R.8
Seipp, C.A.9
Freezer, L.J.10
Morton, K.E.11
Mavroukakis, S.A.12
White, D.E.13
-
26
-
-
3042739497
-
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine
-
Valmori D, Dutoit V, Ayyoub M, et al. Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine. Cancer Immun 2003;3:15-29.
-
(2003)
Cancer Immun
, vol.3
, pp. 15-29
-
-
Valmori, D.1
Dutoit, V.2
Ayyoub, M.3
-
28
-
-
0031952899
-
Conjunctival melanoma
-
DOI 10.1016/S0039-6257(97)00122-7, PII S0039625797001227
-
Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998;42:321-50. (Pubitemid 28092772)
-
(1998)
Survey of Ophthalmology
, vol.42
, Issue.4
, pp. 321-350
-
-
Seregard, S.1
-
29
-
-
0036970876
-
Immunophenotype of conjunctival melanomas: Comparisons with uveal and cutaneous melanomas
-
Iwamoto S, Burrows RC, Grossniklaus HE, et al. Immunophenotype of conjunctival melanomas. Comparisons with uveal and cutaneous melanomas. Arch Ophthalmol 2002;120:1625-9. (Pubitemid 36401795)
-
(2002)
Archives of Ophthalmology
, vol.120
, Issue.12
, pp. 1625-1629
-
-
Iwamoto, S.1
Burrows, R.C.2
Grossniklaus, H.E.3
Orcutt, J.4
Kalina, R.E.5
Boehm, M.6
Bothwell, M.A.7
Schmidt, R.8
-
30
-
-
79955008528
-
Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma
-
Dratviman-Storobinsky O, Cohen Y, Frenkel S, et al. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma. Invest Ophthalmol Vis Sci 2010;51:6180-2.
-
(2010)
Invest Ophthalmol Vis Sci
, vol.51
, pp. 6180-6182
-
-
Dratviman-Storobinsky, O.1
Cohen, Y.2
Frenkel, S.3
-
31
-
-
36248941589
-
Prognostic significance of histopathology of primary conjunctival melanoma in caucasians
-
DOI 10.1080/02713680701648019, PII 785404303
-
Tuomaala S, Toivonen P, Al-Jamal R, et al. Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res 2007;32:939-52. (Pubitemid 350135723)
-
(2007)
Current Eye Research
, vol.32
, Issue.11
, pp. 939-952
-
-
Tuomaala, S.1
Toivonen, P.2
Al-Jamal, R.3
Kivela, T.4
-
32
-
-
7244225178
-
Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanomas
-
2204
-
Anassatsiou G, Esser M, Bader E, et al. Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanomas. Melanoma Res 2204;14:381-5.
-
Melanoma Res
, vol.14
, pp. 381-385
-
-
Anassatsiou, G.1
Esser, M.2
Bader, E.3
-
33
-
-
79953276590
-
Detection of M2 macrophages in uveal melanoma and relation with survival
-
Bronkhurst IH, Long LV, Jordanova ES, et al. Detection of M2 macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Sci 2011;52:643-50.
-
(2011)
Invest Ophthalmol Sci
, vol.52
, pp. 643-650
-
-
Bronkhurst, I.H.1
Long, L.V.2
Jordanova, E.S.3
-
34
-
-
33646083008
-
Directions in the immune targeting of cancer: Lessons learned from the cancer-testis Ag NY-ESO-1
-
Nicholaou T, Ebert L, Davis ID, et al. Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1. Immunol Cell Biol 2006;8:303-17.
-
(2006)
Immunol Cell Biol
, vol.8
, pp. 303-317
-
-
Nicholaou, T.1
Ebert, L.2
Davis, I.D.3
-
35
-
-
77958543711
-
Expression of MCSP and PRAME in conjunctival melanoma
-
Westekemper H, Karimi S, Süsskind D, et al. Expression of MCSP and PRAME in conjunctival melanoma. Br J Ophthalmol 2010;94:1322-7.
-
(2010)
Br J Ophthalmol
, vol.94
, pp. 1322-1327
-
-
Westekemper, H.1
Karimi, S.2
Süsskind, D.3
-
36
-
-
79954455826
-
Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetylase inhibitor MGCD0103
-
Moreno-Bost A, Szmania S, Stone K, et al. Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetylase inhibitor MGCD0103. Cytotherapy 2011;13:618-28.
-
(2011)
Cytotherapy
, vol.13
, pp. 618-628
-
-
Moreno-Bost, A.1
Szmania, S.2
Stone, K.3
-
37
-
-
65249110495
-
In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells
-
Cunneen TS, Conway RM, Madigan MC. In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. Arch Ophthalmol 2009;127:414-20.
-
(2009)
Arch Ophthalmol
, vol.127
, pp. 414-420
-
-
Cunneen, T.S.1
Conway, R.M.2
Madigan, M.C.3
|